What Is LED Photobiomodulation?
Photobiomodulation (PBM) is defined as a form of light therapy that utilizes non-ionizing light sources — including lasers, light-emitting diodes (LEDs), and broadband light — in the visible (400–700 nm) and near-infrared (700–1100 nm) electromagnetic spectrum to elicit beneficial biological effects. It is a non-thermal process: unlike surgical or ablative lasers, PBM does not generate heat sufficient to damage tissue. Instead, it works through photophysical and photochemical interactions with endogenous cellular chromophores.[1][2][^3]
The therapy was first developed in the 1960s, when Endre Mester demonstrated that low-power ruby laser light could accelerate wound healing in mice. NASA researchers later employed it to enhance healing in space environments. For decades, it was known primarily as "low-level laser therapy" (LLLT) or "cold laser therapy." The terminology was formally standardized in 2015 when the National Library of Medicine added "photobiomodulation therapy" (PBMT) to its MeSH database as the preferred term.[4][3]
Why LEDs Specifically?
While lasers initiated PBM research, LEDs have become increasingly prevalent for several evidence-supported reasons:[5][6]
Safety profile: LEDs produce non-coherent, divergent light with no laser-associated eye hazard requiring the same safety precautions as class III/IV therapeutic lasers
Large-area irradiation: LEDs can simultaneously treat large tissue surface areas, unlike a point laser
Wearable and home-use potential: LED arrays can be integrated into flexible, wearable devices
Cost efficiency: LEDs deliver comparable photon energy at significantly lower cost per milliwatt
Clinical equivalence: Published research confirms that LEDs and lasers produce comparable PBM effects when matched for wavelength, power density, and dose[6][5]
"LED photobiomodulation is here to stay." — Hamblin & Huang, Photochemical & Photobiological Sciences, 2018[^5]
